NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.9402
-0.0269 (-2.78%)
Jan 22, 2026, 11:36 AM EST - Market open
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $27.92 million as of January 22, 2026. Its market cap has increased by 1.47% in one year.
Market Cap
27.92M
Enterprise Value
28.06M
1-Year Change
1.47%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $27.92M, a decrease of -56.78%. That is a compound annual growth rate of -18.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 28.72M | 25.76% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 30.39M |
| Pluri | 30.03M |
| Palatin Technologies | 29.89M |
| Werewolf Therapeutics | 29.03M |
| Barinthus Biotherapeutics | 28.99M |
| Rallybio | 28.89M |
| Senti Biosciences | 28.39M |
| Boundless Bio | 27.76M |